Direct-to-consumer advertising of prescription drugs: balancing benefits and risks, and a way forward.
Kravitz
R L
RL
Department of Internal Medicine, University of California, Davis, California, USA. rlkravitz@ucdavis.edu
Bell
R A
RA
D003257:Consumer Product Safety; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D004346:Drug Information Services / Q000191:economics / Q000331:legislation & jurisprudence; D011307:Drug Prescriptions; D004358:Drug Therapy / Q000191:economics; D004335:Drug and Narcotic Control; D064420:Drug-Related Side Effects and Adverse Reactions; D007722:Health Knowledge, Attitudes, Practice; D006293:Health Promotion; D006801:Humans; D008389:Marketing of Health Services / Q000191:economics / Q000331:legislation & jurisprudence; D008402:Mass Media; D017059:Models, Econometric; D010353:Patient Education as Topic; D010565:Persuasive Communication; D010819:Physician's Role; D010818:Practice Patterns, Physicians'; D011358:Product Surveillance, Postmarketing; D018570:Risk Assessment